Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
基本信息
- 批准号:10706874
- 负责人:
- 金额:$ 20.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAcquired Immunodeficiency SyndromeAcuteAddressAdherenceAdministratorAdultAffectAftercareAreaBehavioralCaringCause of DeathCessation of lifeCharacteristicsChronic DiseaseChronic Obstructive Pulmonary DiseaseClinicCognitiveCognitive TherapyCounselingDangerousnessDataDevelopmentDisease OutcomeDistressElementsEnsureEpidemicFocus GroupsFundingFutureGeneral PopulationHIVHIV/TBHealthIndividualInterventionInterviewLinkLung diseasesMaintenanceManualsModelingMorbidity - disease rateNational Institute of Drug AbuseNational Institute of Mental HealthNewly DiagnosedOutcomePathway interactionsPatientsPersonsPrevalenceProceduresProfessional counselorProtocols documentationProviderPublic HealthPulmonary TuberculosisRandomizedRandomized, Controlled TrialsRelapseReportingResearchResearch PersonnelResource-limited settingResourcesRiskRisk FactorsSmokeSmokerSmokingSmoking Cessation InterventionSmoking treatmentSouth AfricaSouth AfricanSpecific qualifier valueSputumStructureSymptomsTestingTobaccoTobacco smokeTobacco useTreatment FailureTreatment outcomeTuberculosisUnited StatesViral Load resultWomanWorkWorld Health Organizationacceptability and feasibilityantiretroviral therapyarmcigarette smokecomparison controldesigneffectiveness trialeffectiveness/implementation trialevidence baseexperiencefollow up assessmentfollow-upfuture implementationhigh riskimplementation interventionimplementation/effectivenessimprovedinnovationintervention refinementlow and middle-income countriesmenmortalitynegative affectnovelperi-urbanpoor health outcomeprogramspsychoeducationpsychoeducationalrecruitsecondary outcomeskillssmoking abstinencesmoking cessationsmoking prevalencetherapy adherencetherapy developmenttobacco abstinencetreatment adherencetreatment as usualtreatment strategytrial comparingtuberculosis treatment
项目摘要
Overview: This proposal directly addresses one of the most critical public health challenges impacting the
health and survival of people with HIV (PWH) and/or tuberculosis (TB) in South Africa (SA): smoking.
Background/Significance: Smoking reduces antiretroviral therapy (ART) adherence among PWH,
compromising HIV treatment outcomes, and is linked to lower TB treatment adherence among patients newly
diagnosed with TB, as well as to TB treatment failure, loss to follow up during treatment, and death during or
after treatment.
Preliminary studies: In this R34 application, we propose to develop a smoking cessation intervention tailored
to the SA context that improves disease outcomes for both HIV and TB, bringing together our experience from
two overlapping areas of research. First, we completed a randomized controlled trial (RCT) that established initial
efficacy, feasibility, and acceptability of a cognitive behavioral therapy smoking cessation intervention (QUIT) for
PWH in the US, which increased biologically-verified abstinence rates at 6 months compared to controls.1
Second, we recently completed an efficacy/effectiveness trial of a cognitive behavioral ART adherence
intervention, which successfully increased HIV treatment adherence and reduced viral load among PWH in Cape
Town.2 Therefore, our US- and SA-based investigator team has expertise in smoking cessation treatment
development for individuals with chronic disease and in adapting evidence-based, cognitive behavioral strategies
for treatment adherence in a low-resource setting.
Approach: We now propose to extend this body of work by developing QUIT-AD, a novel intervention which will
integrate our QUIT program with cognitive behavioral strategies that have been culturally adapted to improve
treatment adherence among PWH and/or TB in SA. To do so, we will: more thoroughly understand (a) barriers
to smoking cessation among adults with HIV and/or TB and (b) barriers to TB treatment adherence among adults
with TB who use tobacco (Aim 1); adapt the QUIT protocol, adding and removing content as appropriate based
on the formative data, and conduct a small proof-of-concept open trial (n = 5; Aim 2); and assess the feasibility
and acceptability of the intervention in a pilot RCT to be task shifted to lay counselors (Aim 3). Secondary
outcomes of the RCT will be biologically-verified point prevalence tobacco abstinence, number of cigarettes
smoked in the past week, and favorable HIV/TB treatment outcome at 6 months.
Outcomes/next steps: These aims will lay the groundwork for a full-scale, hybrid effectiveness/implementation
trial which could change the smoking cessation treatment landscape in SA, provide an empirically supported
program for PWH and/or TB, and serve as a model for future work to sustain smoking abstinence among
individuals with chronic diseases in resource-limited settings.
概述:该提案直接解决了影响世界卫生组织的最关键的公共卫生挑战之一。
南非(SA)艾滋病毒(PWH)和/或结核病(TB)感染者的健康和生存:吸烟。
背景/意义:吸烟降低了PWH患者的抗逆转录病毒治疗(ART)依从性,
损害艾滋病毒治疗结果,并与新感染者结核病治疗依从性降低有关。
被诊断出患有结核病,以及结核病治疗失败、治疗期间失去随访以及治疗期间死亡
治疗后
初步研究:在这个R34应用中,我们建议开发一种量身定制的戒烟干预措施。
到SA的背景下,改善艾滋病毒和结核病的疾病结果,汇集我们的经验,
两个重叠的研究领域。首先,我们完成了一项随机对照试验(RCT),
认知行为疗法戒烟干预(QUIT)的有效性、可行性和可接受性
美国的PWH,与对照组相比,6个月时经生物学验证的禁欲率增加。
其次,我们最近完成了一项认知行为ART依从性的功效/有效性试验,
干预措施,成功地提高了艾滋病毒治疗的依从性,并降低了开普敦PWH中的病毒载量
Town.2因此,我们的美国和SA研究团队拥有戒烟治疗方面的专业知识
发展为个人与慢性疾病和适应证据为基础的,认知行为策略
在资源匮乏的环境下坚持治疗。
方法:我们现在建议通过开发QUIT-AD来扩展这项工作,这是一种新的干预措施,
将我们的QUIT计划与认知行为策略相结合,这些策略在文化上已经适应,
SA中PWH和/或TB的治疗依从性。要做到这一点,我们将:更彻底地了解(一)障碍
艾滋病毒和/或结核病成人患者戒烟的障碍和(B)成人结核病治疗依从性的障碍
吸烟的结核病患者(目标1);调整QUIT协议,根据情况添加和删除内容
在形成性数据上,进行一项小型概念验证开放试验(n = 5;目标2);并评估可行性
和干预的可接受性,在试点RCT的任务转移到外行辅导员(目标3)。二次
随机对照试验的结果将是生物学验证的点患病率、戒烟率、吸烟数量
在过去一周内吸烟,6个月时艾滋病毒/结核病治疗结果良好。
成果/今后的步骤:这些目标将为全面、混合的有效性/执行奠定基础
一项可能改变SA戒烟治疗前景的试验,提供了经验支持
计划,并作为未来工作的模式,以维持戒烟,其中
在资源有限的环境中,慢性病患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Conall Michael O'Cleirigh其他文献
Conall Michael O'Cleirigh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Conall Michael O'Cleirigh', 18)}}的其他基金
Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV
解决艾滋病毒感染者戒烟和焦虑/抑郁问题的综合治疗的有效性
- 批准号:
10400306 - 财政年份:2021
- 资助金额:
$ 20.49万 - 项目类别:
Effectivenss of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV
综合治疗解决艾滋病毒感染者戒烟和焦虑/抑郁问题的有效性
- 批准号:
10349475 - 财政年份:2019
- 资助金额:
$ 20.49万 - 项目类别:
Effectivenss of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV
综合治疗解决艾滋病毒感染者戒烟和焦虑/抑郁问题的有效性
- 批准号:
9926444 - 财政年份:2019
- 资助金额:
$ 20.49万 - 项目类别:
Effectivenss of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV
综合治疗解决艾滋病毒感染者戒烟和焦虑/抑郁问题的有效性
- 批准号:
9925766 - 财政年份:2019
- 资助金额:
$ 20.49万 - 项目类别:
Nurse-Delivered CBT for Depression-Adherence in HIV Primary Care S. Africa
护士为南非艾滋病毒初级保健中的抑郁症依从性提供 CBT
- 批准号:
9127808 - 财政年份:2015
- 资助金额:
$ 20.49万 - 项目类别:
Nurse-Delivered CBT for Depression-Adherence in HIV Primary Care S. Africa
护士为南非艾滋病毒初级保健中的抑郁症依从性提供 CBT
- 批准号:
8991805 - 财政年份:2015
- 资助金额:
$ 20.49万 - 项目类别:
Integrated Behavioral Treatment for Chronic Pain/Drug Use in Older MSM with HIV
针对老年 HIV 感染男男性行为者的慢性疼痛/药物使用的综合行为治疗
- 批准号:
9000143 - 财政年份:2015
- 资助金额:
$ 20.49万 - 项目类别:
Integrated Treatment for Smoking Cessation & Anxiety in People with HIV
戒烟综合治疗
- 批准号:
8209316 - 财政年份:2011
- 资助金额:
$ 20.49万 - 项目类别:
HIV Prevention and Trauma Treatment for MSM with Childhood Sexual Abuse Histories
有童年性虐待史的 MSM 的艾滋病毒预防和创伤治疗
- 批准号:
8664432 - 财政年份:2011
- 资助金额:
$ 20.49万 - 项目类别:
Integrated Treatment for Smoking Cessation & Anxiety in People with HIV
戒烟综合治疗
- 批准号:
8470608 - 财政年份:2011
- 资助金额:
$ 20.49万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 20.49万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 20.49万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 20.49万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 20.49万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 20.49万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 20.49万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 20.49万 - 项目类别:














{{item.name}}会员




